Cited in | International search | Type: | Patent literature | Publication No.: | EP1749537
[Y] (LAB FRANCAIS DU FRACTIONNEMENT [FR]) [Y] 1-23 * abstract *; | Type: | Patent literature | Publication No.: | EP1388544
[Y] (D COLLEN RES FOUNDATION VZW [BE]) [Y] 1-23 * abstract *; | Type: | Patent literature | Publication No.: | WO2005016455
[DY] (D COLLEN RES FOUNDATION VZW [BE], et al) [DY] 1-23 * example 12; sequences 29-32 *; | Type: | Patent literature | Publication No.: | WO2007096536
[E] (LAB FRANCAIS DU FRACTIONNEMENT [FR], et al) [E] 1-23 * the whole document *; | Type: | Patent literature | Publication No.: | FR2897868
[E] (LAB FRANCAIS DU FRACTIONNEMENT [FR]) [E] 1-23 * Identique à la présente demande.;; claims 1-29 * | Type: | Non-patent literature | Publication information: | [Y] - GILLES JEAN GUY G ET AL, "A limited number of anti-idiotypic antibodies is required to maintain FVIII function in presence of polyclonal anti-FVIII antibodies of haemophilia a patients with inhibitors.", BLOOD, & 48TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ORLANDO, FL, USA; DECEMBER 09 -12, 2006, (200611), vol. 108, no. 11, Part 1, ISSN 0006-4971, page 299A, XP009099673 [Y] 1-23 * the whole document * | Type: | Non-patent literature | Publication information: | [Y] - GILLES JEAN GUY G ET AL, "In vivo neutralization of a C2 domain-specific human anti-Factor VIII inhibitor by an anti-idiotypic antibody", BLOOD, (20040401), vol. 103, no. 7, ISSN 0006-4971, pages 2617 - 2623, XP002479159 [Y] 1-23 * abstract * | DOI: | http://dx.doi.org/10.1182/blood-2003-07-2207 | Type: | Non-patent literature | Publication information: | [A] - PIPE S W ET AL, "New high-technology products for the treatment of haemophilia", HAEMOPHILIA, BLACKWELL SCIENCE, OXFORD, GB, (20041001), vol. 10, no. SUPPL 4, ISSN 1351-8216, pages 55 - 63, XP002404355 [A] * page 58, column R, paragraph 2 - page 59, column L, paragraph 1 * |